News from cannabis science, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 15, 2014, 08:04 ET
Dec 09, 2014, 07:01 ET

Cannabis Science (CBIS) Joins Forces With The Constituency For Africa (CFA) To Focus On Improving Healthcare Infrastructure In Africa In 2015

 Cannabis Science, Inc. (OTCQB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, is...

Dec 05, 2014, 07:33 ET

Cannabis Science (CBIS) Readies To Launch New Products In California With Apothocary Genetics

Cannabis Science, Inc. (OTCQB: CBIS), a U.S. company specializing in global cannabis formulation-based drug development and consulting, is in the...

Nov 24, 2014, 09:15 ET

Cannabis Science (CBIS) Purchases Two Parcels of Cannabis Production Land from Apothecary Genetics, a Combined Total of 51 Acres; Licenses Land, Cultivation, and Formulation Usage in Major Growth Plan in California

In a move that signals a forceful reinvestment in the largest legal medical cannabis market, Cannabis Science, Inc. (OTC: CBIS), a U.S. company...

Nov 20, 2014, 07:17 ET

Cannabis Science Advances its Move into African Market from HIV to Cancer to the Ebola Virus With a Series of High-Level Meetings in Washington, D.C.

As part of its multi-pronged move into Africa, the CEO of Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in global cannabis...

Nov 13, 2014, 14:07 ET

Demand For Cannabis Science Drug Increases As Company Moves Into 2nd Stage Of Protocols For Pre-Clinical Drug Development, Thanks To Positive Laboratory Results From Its Operations In Spain

Cannabis Science, Inc. (OTC: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, is pleased...

Nov 07, 2014, 14:32 ET
This is one of several growing rooms located in the facility.

Cannabis Science, Inc. (CBIS) Is In The Final Stages To Acquire A British Columbia Company That Has Submitted 'Marihuana for Medical Purposes' Application To Health Canada (As Previously Announced)

 Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in cannabis formulation-based drug development and related consulting, is...

Nov 06, 2014, 06:45 ET

Cannabis Science Announces Corporate Changes, Appointing Raymond Dabney As President And CEO And Dr. Dorothy Bray As Scientific Advisory Board Chair And Clinical Development Consultant

 Cannabis Science, Inc. (OTC: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, is...

Nov 05, 2014, 13:53 ET

Cannabis Science Enthused With CNN Monitoring The Outcome Of The National State By State Voting To Legalize Medical Cannabis

 Cannabis Science, Inc. (OTC: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, is...

Oct 28, 2014, 08:51 ET

Cannabis Science Releases Positive Laboratory Results From Both The EU Certified As Well As Its Own Unique Cannabis Strains Grown In Its Spain Operations

Cannabis Science, Inc. (OTC: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting is very...

Sep 29, 2014, 13:56 ET
Sep 16, 2014, 09:05 ET

Cannabis Science, Inc. (CBIS) And Unistraw Holdings Join Forces To Produce Proprietary Formulations Delivering A Wide Array Of Unique Cannabis Extracts And Pure Cannabinoid-Based Products

Cannabis Science, Inc. (OTC: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, is pleased...

Aug 25, 2014, 11:17 ET

Cannabis Science, Inc. (CBIS) In Final Negotiations To Acquire British Columbia Company That Has Submitted 'Marihuana For Medical Purposes' License Application To Health Canada

 Cannabis Science, Inc. (OTC-QB: CBIS), a U.S. company specializing in cannabis formulation-based drug development and related consulting, is...

Aug 22, 2014, 08:51 ET

Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France

 Cannabis Science, Inc. (OTC: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, is...

Aug 11, 2014, 11:16 ET

Cannabis Science, Inc. (CBIS) Increases Equity Position to 50.1% in Michigan Green Technologies LLC, Positioning Company as Leader in Evolving Michigan Medical Cannabis and Hemp Industries

Cannabis Science, Inc. (OTC-QB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, signs...

Aug 07, 2014, 11:55 ET

Cannabis Science In Final Negotiations To Establish Its First Medical Cannabis Facilities In Canada

 Cannabis Science, Inc. (OTC-QB:CBIS), a U.S. company specializing in cannabis formulation-based drug development and related consulting, is in...

Aug 05, 2014, 11:23 ET

Cannabis Science, Inc. (CBIS) Encouraged by Florida Medical Cannabis Voter Support of 88 Percent; Florida Referendum in November Seen as Key Tipping Point

Cannabis Science, Inc. (OTC-QB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, is...

Aug 05, 2014, 09:06 ET